Archives

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
Have UK housebuilders finally found their floor after June's surprise price rise?
Infrastructure and Real Estate

Have UK housebuilders finally found their floor after June's surprise price rise?

Highlights,Lender figures show national house prices rose in June, the first monthly increase after a run of declines.,Expectations of further interest rate cuts are feeding hopes of improving mortgage affordability.,Housebuilder shares have whipsawed thi...

Could Atlantic Lithium (AIM:ALL) Be the AIM Story That Defines Ghana's Battery Ambitions?
Lithium Stocks

Could Atlantic Lithium (AIM:ALL) Be the AIM Story That Defines Ghana's Battery Ambitions?

Highlights,Atlantic Lithium's Ewoyaa project has cleared key ratification hurdles in Ghana's parliament.,Strategic funding interest from China's Huayou has intensified the corporate narrative around the company.,Ghana is positioning Ewoyaa as its first li...

Has Kodal Minerals (AIM:KOD) Quietly Become West Africa's Newest Lithium Producer?
Lithium Stocks

Has Kodal Minerals (AIM:KOD) Quietly Become West Africa's Newest Lithium Producer?

Highlights,Kodal Minerals is ramping up spodumene production at its Bougouni project in southern Mali.,The company has been preparing shipments for export as it completes its transition to producer status.,Quarterly progress updates have become the key ma...

Why are Segro shareholders demanding more from the American suitor at the gates?
Infrastructure and Real Estate

Why are Segro shareholders demanding more from the American suitor at the gates?

Highlights,Segro has rejected a takeover approach from US warehouse giant Prologis, calling it opportunistic, one-sided and inadequate.,Several investors are publicly urging the American bidder to come back with improved terms.,The tussle underlines a bro...

Is Savannah Resources (LSE:SAV) About to Answer Europe's Biggest Lithium Question?
Lithium Stocks

Is Savannah Resources (LSE:SAV) About to Answer Europe's Biggest Lithium Question?

Highlights,Savannah Resources has targeted this month for delivery of updated studies on its Barroso lithium project.,Barroso is widely viewed as Western Europe's most significant conventional spodumene development.,European policy support for domestic ba...

Is GSK's respiratory shot about to reach a whole new patient group?
Healthcare Stocks

Is GSK's respiratory shot about to reach a whole new patient group?

Highlights,The US regulator has accepted GSK's application to review expanded use of its respiratory syncytial virus vaccine in younger high-risk adults.,A wider label would extend the shot beyond older populations into a fresh commercial segment.,Vaccine...

Why is Smith & Nephew drifting while an activist quietly builds its stake this week?
Top Stories

Why is Smith & Nephew drifting while an activist quietly builds its stake this week?

Highlights,Activist investor Cevian Capital has raised its holding in Smith & Nephew, cementing its position among the company's most influential shareholders.,The shares have softened even as the wider London market has pushed higher in recent sessions.,...

Could The Castlelake Approach Rewrite easyJet's (LSE:EZJ) Growth Story Today?
Top Stories

Could The Castlelake Approach Rewrite easyJet's (LSE:EZJ) Growth Story Today?

Highlights,easyJet has reached an agreement in principle to be acquired by US investment firm Castlelake, one of the biggest potential UK airline deals in years.,The shares are changing hands below the mooted offer level, reflecting caution over whether E...

Is Sage Group (LSE:SGE) Turning AI Adoption Into Its Next Growth Chapter This Week?
Technology Stocks

Is Sage Group (LSE:SGE) Turning AI Adoption Into Its Next Growth Chapter This Week?

Highlights,Sage shares have appeared among the stronger large-cap technology performers in London during recent sessions.,Investors are focused on the software group's ongoing buyback programme and the momentum in its cloud-native revenue.,A quarterly tra...

Can AstraZeneca's new heart pill keep the pharma rally alive this week?
Healthcare Stocks

Can AstraZeneca's new heart pill keep the pharma rally alive this week?

Highlights,AstraZeneca's first-in-class aldosterone synthase inhibitor for hard-to-treat hypertension has been cleared for use in the United States.,The group's oral small-molecule weight and metabolic candidate is moving into late-stage clinical developm...